McLaren Andrew James, Friend Peter John
Nuffield Department of Surgery, John Radclffe Hospital, Oxford, UK.
Transpl Int. 2003 Oct;16(10):701-8. doi: 10.1007/s00147-003-0659-2. Epub 2003 Oct 7.
Organ preservation aims to provide a viable graft with primary function post-transplant. The current basis of preservation for transplantation is static cold storage using specific preservation solutions which minimise cellular swelling and membrane pump activity, thus maintaining cellular ATP levels. The current organ shortage and consequent expansion of donor criteria places even greater reliance on minimising graft injury during preservation. This review focuses on current and future advances in preservation technology. The key areas of advance are additives to preservation solutions, alternatives/adjuncts to preservation solutions including perfluorocarbons. A major area of advance is in the modulation of organs during the storage period. This may be achieved by biochemical additives or genetic manipulation. Machine perfusion technology is improving, and this is discussed together with the recent concept of warm (normothermic) perfusion as an alternative means of preservation. The authors provide an overview over the current methods of organ preservation. Cold storage, effective in the short-term is insufficient for marginal organs, does not allow assessment of viability markers, and provokes ischaemic injury. Potential strategies for minimising ischaemic injury include additives to preservation solutions; the two-layer method with perfluorcarbons and UW solution-at present limited to pancreas preservation; organ modulation; organ preconditioning and genetic modification of organs. In particular, the authors illuminate the potential in a reappraisal of the concept of normothermic perfusion.
器官保存旨在提供一个移植后具有主要功能的有活力的移植物。当前移植保存的基础是使用特定的保存溶液进行静态冷藏,这种溶液可使细胞肿胀和膜泵活性降至最低,从而维持细胞内三磷酸腺苷(ATP)水平。当前器官短缺以及随之而来的供体标准的扩大,使得在保存过程中最大程度地减少移植物损伤变得更加重要。本综述聚焦于保存技术的当前进展和未来发展。进展的关键领域包括保存溶液的添加剂、保存溶液的替代物/辅助物(包括全氟化碳)。一个主要的进展领域是在保存期间对器官进行调控。这可以通过生化添加剂或基因操作来实现。机器灌注技术正在改进,本文将对其以及作为一种替代保存方式的温热(常温)灌注这一最新概念一同进行讨论。作者对当前的器官保存方法进行了概述。短期有效的冷藏对于边缘器官来说是不够的,它不允许评估活力标志物,并且会引发缺血性损伤。将缺血性损伤降至最低的潜在策略包括保存溶液的添加剂;全氟化碳和UW溶液的两层法——目前仅限于胰腺保存;器官调控;器官预处理以及器官的基因改造。特别是,作者阐明了重新评估常温灌注概念的潜力。